Antibody key to treating variant CJD, scientists find

Scientists at the University of Liverpool have determined the atomic structure of the 'binding' between a brain protein and an antibody that could be key to treating patients with diseases such as variant CJD.

If you want to include this story in your blog, copy and paste this formatted text: